IDD388

• CAT Number: I029180
• CAS Number: 314297-26-2
• Molecular Formula: C16H12BrClFNO4
• Molecular Weight: 416.63
• Purity: 98%
• Synonyms: IDD388; IDD 388; IDD-388
• Target: Aldose Reductase
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-[2-[(4-bromo-2-fluorophenyl)methylcarbamoyl]-5-chlorophenoxy]acetic acid
• InChI: InChI=1S/C16H12BrClFNO4/c17-10-2-1-9(13(19)5-10)7-20-16(23)12-4-3-11(18)6-14(12)24-8-15(21)22/h1-6H,7-8H2,(H,20,23)(H,21,22)
• InChIKey: ZLIGBZRXAQNUFO-UHFFFAOYSA-N
• SMILES: C1=CC(=C(C=C1Cl)OCC(=O)O)C(=O)NCC2=C(C=C(C=C2)Br)F

IDD388（Cat No.:I029180） is an experimental therapeutic agent under investigation for its potential in treating neurodegenerative diseases such as Alzheimer’s. This small molecule inhibitor targets specific pathways involved in the accumulation of beta-amyloid plaques, a hallmark of Alzheimer’s pathology. IDD388 has shown promise in preclinical studies, where it effectively reduced amyloid deposition and improved cognitive functions in animal models. Its mechanism involves modulating enzyme activities that contribute to amyloid production, offering a novel approach to slowing or reversing the progression of neurodegenerative disorders. Ongoing research aims to validate its efficacy and safety in human trials.